Physician profile
Jason E Wagner
NPI 1588729768
$3,464.50
in general payments reported to CMS, 2019-2025
27 companies · $684 in 2025
The $684 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $200 · 2021: $480 · 2022: $1,048 · 2023: $511 · 2024: $427 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,622.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,103.79 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Abiomed | $340.45 | 2022-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $281.59 | 2020-2025 | Spiriva Respimat, Stiolto Respimat, Jascayd |
| Astrazeneca Pharmaceuticals LP | $184.31 | 2020-2025 | Fasenra, Breztri, Tezspire |
| Abbvie INC. | $159.17 | 2022-2024 | Dalvance, Avycaz |
| Mylan Specialty L.P. | $147.19 | 2020-2024 | Yupelri |
| Boston Scientific Corporation | $142.42 | 2022 | |
| Janssen Pharmaceuticals, INC | $136.83 | 2021-2022 | |
| Baxter Healthcare | $122.73 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Insmed, INC. | $116.15 | 2022-2025 | Arikayce |
| Grifols USA, LLC | $110.44 | 2021-2024 | Prolastin-C Liquid |
| Abbott Laboratories | $98.17 | 2019 | |
| Gilead Sciences, INC. | $93.63 | 2021-2023 | Veklury |
| Verona Pharma, INC. | $69.02 | 2025 | Ohtuvayre |
| Actelion Pharmaceuticals US, INC. | $63.63 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $49.74 | 2023-2025 | Smartvest |
| Philips North America LLC | $43.09 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $25.53 | 2025 | Acthar |
| Shionogi INC | $24.20 | 2025 | Fetroja |
| Ani Pharmaceuticals, INC. | $23.80 | 2024 | Purified Cortrophin Gel |
| Genentech USA, INC. | $23.69 | 2022 | |
| Ambu INC. | $22.18 | 2022 | |
| Genzyme Corporation | $19.14 | 2024 | |
| United Therapeutics Corporation | $17.88 | 2023 | Tyvaso |
| Alk-Abello, INC | $15.72 | 2024 | Grastek, Odactra, Ragwitek |
| Pfizer INC. | $15.60 | 2022 | |
| Tactile Systems Technology INC | $14.41 | 2024 | Entre Plus, Flexitouch Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Wagner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.